Nancy E. Dempze’s Bristol-Myers Squibb BMY Stock Holding History

Nancy E. Dempze’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-12,575	Closed	-$651K	–	97
2024 Q3	$651K	Buy	+12,575	New	+$590K	0.36%	60

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nancy E. Dempze's BMY Position: Q4 2024 in Review

Nancy E. Dempze sold out of Bristol-Myers Squibb (BMY) in Q4 2024, closing a stake of 12,575 shares — an estimated $651K sold.

Nancy E. Dempze first reported a position in BMY in Q3 2024 and held it in 1 quarter. The position peaked at $651K in Q3 2024. 2,487 funds tracked by Wall St. Rank hold BMY as of Q4 2024.

Nancy E. Dempze reported no remaining Bristol-Myers Squibb position as of Q4 2024 after selling out during the quarter.
Nancy E. Dempze sold 12,575 Bristol-Myers Squibb shares in Q4 2024, an estimated $651K.
Nancy E. Dempze first reported a position in Bristol-Myers Squibb in Q3 2024 and held it in 1 quarter.
Nancy E. Dempze's Bristol-Myers Squibb position peaked at $651K in Q3 2024.
2,487 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2024.

Based on Nancy E. Dempze's 13F filing for Q4 2024, filed 13 Feb 2025.